Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: A population-based cohort study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 1, 2016, Pages 12-19

  Wannamethee, S G ^a   Shaper, A G ^a   Lennon, L ^a   Papacosta, O ^a   Whincup, P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Mortality; Serum sodium; Stroke

Indexed keywords

POTASSIUM; SODIUM; BIOLOGICAL MARKER;

ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLIICAL EVALUATIO; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HUMAN; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; AGE; AGED; BLOOD; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY DISEASE; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; STROKE; TIME FACTOR; UNITED KINGDOM;

AGE FACTORS; AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY DISEASE; HUMANS; HYPERNATREMIA; HYPONATREMIA; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SODIUM; STROKE; TIME FACTORS; UNITED KINGDOM;

EID: 84952976802     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2015.07.008     Document Type: Article

References (32)

1. Adrogué H.J., Madias N.E. Hyponatremia N Engl J Med 2000, 342(21):1581-1589. Review.
2. Schriers R.W., Sharma S., Shchekochikhin Hyponatremia: more than just a marker of disease severity?. Nat Rev Nephrol 2012, 9(1):37-50.
3. Hoorn E.J., Zietse R. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis 2013, 62(1):139-149.
4. Rusinaru D., Tribouilloy C., Berry C., Richards A.M., Whalley G.A., Earle N., et al. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur J Heart Fail 2012, 14:1139-1146. MAGGIC Investigators.
5. Goldberg A., Hammerman H., Petcherski S., Nassar M., Zdorovyak A., Yalonetsky S., et al. Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med 2006, 166(7):781-786.
6. Kovesdy C.P., Lott E.H., Lu J.L., Malakauskas S.M., Ma J.Z., Molnar M.Z., et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012, 125:677-684.
7. Decaux G. Is asymptomatic hyponatremia really asymptomatic?. Am J Med 2006, 119(7 Suppl 1):S79-S82. Review.
8. Gankam-Kengne F., Ayers C., Khera A., de Lemos J., Maalouf N.M. Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int 2013, 83:700-706.
9. Sajadieh A., Binici Z., Mouridsen M.R., Nielsen O.W., Hansen J.F., Haugaard S.B. Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 2009, 122:679-686.
10. Liamis G., Rodenburg E.M., Hofman A., Zietse R., Stricker B.H., Hoorn E.J. Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 2013, 126:256-263.
11. Wannamethee G., Whincup P.H., Shaper A.G., Lever A.F. Serum sodium concentration and risk of stroke in middle-aged males. J Hypertens 1994, 12(8):971-979.
12. Mazza A., Pessina A.C., Pavei A., Scarpa R., Tikhonoff V., Casiglia E. Predictors of stroke mortality in elderly people from the general population. The Cardiovascular Study in the Elderly. Eur J Epidemiol 2001, 17:1097-1104.
13. Schlanger L.E., Bailey J.L., Sands J.M. Electrolytes in the aging. Adv Chronic Kidney Dis 2010, 17:308-319.
14. Shaper A.G., Pocock S.J., Walker M., Cohen N.M., Wale C.J., Thomson A.G. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. BMJ 1981, 283(6285):179-186.
15. Wannamethee S.G., Lowe G.D.O., Whincup P.H., Rumley A., Walker M., Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002, 105(15):1785-1790.
16. Wannamethee S.G., Shaper A.G., Lennon L., Whincup P.H. Decreased muscle mass and increased central adiposity are independently related to mortality in older men. Am J Clin Nutr 2007, 86(5):1339-1346.
17. Wannamethee S.G., Sattar N., Papacosta O., Lennon L., Whincup P.H. Alkaline phosphatase, serum phosphate, and incident cardiovascular disease and total mortality in older men. Arterioscler Thromb Vasc Biol 2013, 33:1070-1076.
18. Heymsfield S.B., McManus C., Smith J., Stevens V., Smith J. Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area. Am J Clin Nutr 1982, 36:680-690.
19. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
20. Wannamethee S.G., Whincup P.H., Shaper A.G., Rumley A., Lennon L., Lowe G.D. Circulating inflammatory and haemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Throm Haemost 2009, 7:1605-1611.
21. Wannamethee S.G., Welsh P., Lowe G.D., Gudnason V., di Angelantonio E., Lennon L., et al. N-terminal pro-brain natriuretic peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 2011, 58:56-64.
22. Levy G.B. Determination of sodium with ion-selective electrodes. Clin Chem 1981, 27:1435-1438.
23. Walker M., Shaper A.G., Lennon L., Whincup P.H. Twenty year follow-up of a cohort study based in general practices in 24 British towns. J Publ Health Med 2000, 22(4):479-485.
24. Rose G., Blackburn H., Gillum R.F., Prineas R.J. Cardiovascular survey methods 1982, World Health Organisation, Geneva, Switzerland. 2nd ed.
25. Kumar S., Berl T. Sodium. Lancet 1998, 352(9123):220-228.
26. Ayus J.C., Moritz M.L. Bone disease as a new complication of hyponatremia: moving beyond brain injury. Clin J Am Soc Nephrol 2010, 5(2):167-168.
27. Hoorn E.J., Rivadeneira F., van Meurs J.B.J., Ziere G., Stricker B.H., Hofman A., et al. Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Min Res 2011, 26:1822-1828.
28. Sterns R.H., Silver S.M. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med 2006, 119(7A):S12-S16.
29. O'Donnell M., Mente A., Rangarajan S., McQueen M.J., Wang X., Liu L., et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014 Aug 14, 371(7):612-623. PURE Investigators, Erratum in: N Engl J Med. 2014 Sep 25;371(13):1267. 10.1056/NEJMoa1311889.
30. He F.J., Markandu N.D., Sagnella G.A., de Wardener H.E., MacGregor G.A. Plasma sodium: ignored and underestimated. Hypertension 2005, 45:98-102.
31. Tomaschitz A., Pilz S., Ritz E., Meinitzer A., Boehm B.O., März W. Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Eur Heart J 2010, 31:1237-1247.
32. Palevsky P.M., Bhagrath R., Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 1996, 124:197-203.